Stephen F. Chaney

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes

Matthew Fell, Jeffrey M. Witkin, Julie F. Falcone et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 99 citations

Medicine, Neuroscience, Pharmacology +17

Altered performance characteristics in cognitive tasks: comparison of the albino ICR and CD1 mouse strains

Benjamin Adams, Thomas Fitch, Stephen F. Chaney et al. · Behavioural Brain Research · 2002 · 67 citations

Social Sciences, Behavioral Sciences, Psychology +9

Force transducer‐based movement detection in fear conditioning in mice: A comparative analysis

Thomas Fitch, Benjamin Adams, Stephen F. Chaney et al. · Hippocampus · 2002 · 34 citations

Life Sciences, Neurobiology, Neuroscience +15

Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice

Mark J. Benvenga, Stephen F. Chaney, Melvyn Baez et al. · Frontiers in Pharmacology · 2018 · 26 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

The 5-Hydroxytryptamine2A Receptor Antagonist R-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) Attenuates Impulsivity after Both Drug-Induced Disruption (Dizocilpine) and Enhancement (Antidepressant Drugs) of Differential-Reinforcement-of-Low-Rate 72-s Behavior in the Rat

Paul Ardayfio, Mark J. Benvenga, Stephen F. Chaney et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 23 citations

Medicine, Neuroscience, Pharmacology +17